SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-024674
Filing Date
2020-09-01
Accepted
2020-09-01 08:44:53
Documents
5
Period of Report
2020-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea126193-8k_kintaratherap.htm 8-K 70414
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES C-3 ea126193ex3-1_kintaratherap.htm EX-3.1 112455
3 FORM OF PLACEMENT AGENT WARRANT ea126193ex4-1_kintaratherap.htm EX-4.1 105281
4 PRESS RELEASE DATED SEPTEMBER 1, 2020 ea126193ex99-1_kintaratherap.htm EX-99.1 17470
5 GRAPHIC ex4-1_001.jpg GRAPHIC 1654
  Complete submission text file 0001213900-20-024674.txt   309547
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 201153368
SIC: 2834 Pharmaceutical Preparations